Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Net Income: 2015-2024

Historic Net Income for Intellia Therapeutics (NTLA) over the last 10 years, with Dec 2024 value amounting to -$486.5 million.

  • Intellia Therapeutics' Net Income rose 21.02% to -$104.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$445.4 million, marking a year-over-year increase of 8.75%. This contributed to the annual value of -$486.5 million for FY2024, which is 4.51% down from last year.
  • Intellia Therapeutics' Net Income amounted to -$486.5 million in FY2024, which was down 4.51% from -$465.5 million recorded in FY2023.
  • In the past 5 years, Intellia Therapeutics' Net Income ranged from a high of -$134.2 million in FY2020 and a low of -$486.5 million during FY2024.
  • In the last 3 years, Intellia Therapeutics' Net Income had a median value of -$465.5 million in 2023 and averaged -$467.2 million.
  • Data for Intellia Therapeutics' Net Income shows a maximum YoY tumbled of 98.59% (in 2021) over the last 5 years.
  • Over the past 5 years, Intellia Therapeutics' Net Income (Yearly) stood at -$134.2 million in 2020, then plummeted by 98.59% to -$266.6 million in 2021, then slumped by 68.67% to -$449.6 million in 2022, then fell by 3.52% to -$465.5 million in 2023, then fell by 4.51% to -$486.5 million in 2024.